Best Vitelliform Macular Dystrophy
Last Posted: Mar 09, 2023
- Bestrophin 1 gene analysis and associated clinical findings in a Chinese patient with Best vitelliform macular dystrophy.
Lin Ying, et al. Molecular medicine reports 2017 0 (4) 4751-4755
- Clinical and Mutation Analysis of Patients with Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy in Chinese Population.
Gao Tingting, et al. BioMed research international 2018 0 4582816
- Mutation spectrum of the bestrophin-1 gene in a large Chinese cohort with bestrophinopathy.
Gao Feng-Juan, et al. The British journal of ophthalmology 2019 0 (6) 846-851
- Multimodal imaging and genetic analysis of adult-onset best vitelliform macular dystrophy in Chinese patients.
Lin Ying, et al. Experimental and therapeutic medicine 2021 0 (3) 1034
- Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons.
Wang Yingwei, et al. Experimental eye research 2022 0 109217
- Novel and homozygous BEST1 mutations in Chinese patients with Best vitelliform macular dystrophy.
Wong Raymond L M, et al. Retina (Philadelphia, Pa.) 2010 0 (5) 820-7
- The Clinical Features and Genetic Spectrum of a Large Cohort of Chinese Patients With Vitelliform Macular Dystrophies.
Xuan Yi, et al. American journal of ophthalmology 2020 4
- Novel BEST1 Mutations and Special Clinical Features of Best Vitelliform Macular Dystrophy.
Liu Jingshu, et al. Ophthalmic research 2016 4
- Two novel mutations in the bestrophin-1 gene and associated clinical observations in patients with best vitelliform macular dystrophy.
Lin Ying, et al. Molecular medicine reports 2015 8 (2) 2584-8
- Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy.
Tian Rong, et al. Molecular vision 2014 0 1594-604
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 09, 2023
- Content source: